businesspress24.com - Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders
 

Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders

ID: 1243785

(firmenpresse) - SAN ANTONIO, TEXAS -- (Marketwired) -- 07/09/13 -- Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) - In a joint effort to accommodate the growing demand for the company's product, Bio-Solutions Corp. has launched its official online retail store at while maintaining its distribution agreement with the Amazon store Healthy Provisions.

Consumers will now have two options when ordering the product; through or Healthy Provisions on Amazon. This will enable Bio-Solutions Corp. to broaden its consumer base and reach out to clients on a global scale where changing lifestyles and health awareness among consumers is expected to drive the health supplements market in the years to come. Type2 Defense™ will cater to type2 diabetes patients, which are 90-95% of all diabetics.

"The market of diabetes supplements is witnessing a steady growth in the last decade mainly due to the growing awareness among consumers of the effect of consuming health supplements. Some of the major factors driving the global supplements market include the growing global ageing population and the growing concern among consumer to stay healthy and fit. Huge opportunities lie in the diabetes supplement industry, where growth is driven mainly due to the demand from knowledgeable consumers looking for a healthy alternative. Our company is strategically positioned to benefit from this," said Bill Gallagher, president and CEO at Bio-Solutions Corp.

Bio-Solutions Corp. has hired Josh Williams, an independent consultant to brand Type2Defense™ thru mainstream media via multiple channels - including high-profile, profession athlete endorsements.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.







Contacts:
Bio-Solutions Corp.
William Gallagher
Chief Executive Officer
210-373-8104


Bio-Solutions Corp.
Josh Williams
Endorsement Deal Coordinator
312-636-1471


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Bio-Solutions Corporation Comments on Unusual Trading Activity
First Ever Baby Born Through Genetic Derived Human Embryos
Bereitgestellt von Benutzer: Marketwired
Datum: 09.07.2013 - 09:00 Uhr
Sprache: Deutsch
News-ID 1243785
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SAN ANTONIO, TEXAS


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 79 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders
"
steht unter der journalistisch-redaktionellen Verantwortung von

Bio-Solutions Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Bio-Solutions Corp.



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 85


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.